+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Oncology Market - Global Forecast 2026-2032- Product Image
Veterinary Oncology Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Oncology Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305503
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Oncology Market is projected to reach USD 2.09 Billion in 2026. It is expected to continue growing at a CAGR of 14.47%, reaching USD 4.74 Billion by 2032.

Veterinary oncology has moved from a niche specialty into a core pillar of companion animal health care as pets live longer and owners pursue advanced cancer diagnostics and treatment. The American Veterinary Medical Association reports that approximately one in four dogs will develop neoplasia during life, and nearly half of dogs over age ten develop cancer, making early detection, staging, and evidence-based treatment increasingly important.

Growth in veterinary oncology is supported by pet humanization, expanding specialty hospitals, broader access to CT, MRI, ultrasound, cytology, histopathology, immunohistochemistry, flow cytometry, and molecular testing, and the availability of regulator-approved animal cancer therapies. Demand is strongest where referral networks, pet insurance, and board-certified oncology services improve affordability, continuity of care, and clinical decision-making for pet cancer treatment.

Transformative Shifts in the Veterinary Oncology Landscape

The veterinary oncology landscape is shifting from generalized chemotherapy toward multimodal, patient-specific care that combines surgery, radiation therapy, medical oncology, pain management, nutrition, and palliative support. Diagnostic quality is rising as cytology, biopsy, advanced imaging, flow cytometry, immunophenotyping, and molecular assays enable more accurate tumor classification, staging, prognosis, and treatment selection.

A second transformation is commercial and operational. Specialty hospitals are expanding referral capacity, general practitioners are using teleconsultation to triage complex cases, and owners increasingly evaluate treatment based on survival benefit, quality of life, adverse-event management, and transparent cost. These shifts favor providers that can integrate diagnostics, referral pathways, clinical protocols, clinical trial access, and compassionate communication.

Cumulative Impact of Artificial Intelligence on Veterinary Oncology

Artificial intelligence is beginning to affect veterinary oncology across imaging review, digital pathology, clinical documentation, workflow automation, and risk stratification. AI-enabled tools can help detect patterns in radiographs, ultrasound images, CT scans, histology slides, cytology images, and electronic medical records, supporting faster triage and more consistent follow-up for suspected pet cancer cases.

The cumulative impact is operational rather than fully autonomous: AI can reduce diagnostic delays, improve case prioritization, standardize reporting, support clinical decision support, and strengthen real-world evidence generation. However, adoption depends on veterinary-specific validation, explainable models, clinician oversight, data privacy, high-quality annotated datasets, and integration with laboratory information systems and hospital workflows.

Key Regional Insights Across Global Veterinary Oncology

North America remains the most mature regional environment for veterinary oncology, supported by high companion animal ownership, specialty referral networks, pet insurance adoption, advanced diagnostics, and access to board-certified oncologists, particularly in the United States and Canada. Europe follows with strong clinical standards across the European Union and established oncology services in the United Kingdom, Germany, France, Italy, and Spain, although reimbursement, medicine authorization, and referral access vary by country. Russia shows more concentrated development in major urban centers where advanced companion animal care infrastructure is available.

Asia-Pacific is expanding as urban pet ownership, premium veterinary clinics, and advanced diagnostics grow in China, Japan, Australia, South Korea, and India. Japan and Australia have well-established companion animal care systems, while China and India are building specialist capacity alongside rapid growth in urban veterinary services. Latin America is led by Brazil and Mexico, where companion animal populations, private veterinary investment, and diagnostic access are increasing. The Middle East, particularly GCC markets, is developing premium pet care infrastructure supported by high-income urban demand, while Africa remains earlier-stage, with growth concentrated in urban centers, veterinary schools, and private referral practices where pathology, imaging, and specialty surgery are accessible.

Key Group Insights for Veterinary Oncology Demand

Within major economic groups, the G7 anchors veterinary oncology innovation through advanced specialty care, pharmaceutical and diagnostic development, academic research, clinical training, pet insurance penetration, and stronger access to radiation oncology and advanced imaging. The European Union contributes harmonized regulatory oversight, cross-border clinical standards, pharmacovigilance requirements, and strong companion animal health infrastructure, making it central to evidence-based veterinary cancer care and responsible therapeutic adoption.

BRICS markets offer scale and long-term demand potential, especially in Brazil, China, and India, where pet populations, urban clinics, and private veterinary services are expanding, while specialist density remains uneven. ASEAN is gaining relevance through urbanization and premium pet care growth in markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with referral oncology emerging first in higher-income metropolitan areas. GCC countries are investing in high-end veterinary services, modern clinics, and companion animal diagnostics, while NATO countries collectively overlap with many of the world’s strongest biomedical research, animal health, military working dog medicine, and specialty hospital ecosystems.

Key Country Insights in Companion Animal Cancer Care

The United States leads veterinary oncology through deep specialty hospital coverage, FDA-approved pet cancer therapies, advanced diagnostics, oncology residency training, and strong owner willingness to treat. Canada benefits from similar clinical standards and referral pathways, while Mexico and Brazil are expanding oncology access through urban private practices, diagnostic laboratories, and growing companion animal care spending. In Europe, the United Kingdom, Germany, France, Italy, and Spain support mature referral networks, professional oncology expertise, and access to surgery, imaging, chemotherapy, and palliative care, while Russia shows selective development in major cities where specialty services and advanced diagnostics are concentrated.

China and India represent high-potential veterinary oncology environments driven by rising pet ownership, urban clinics, premium pet care, and increasing diagnostic investment, though specialist availability and access to advanced therapies remain uneven. Japan has a sophisticated small animal veterinary sector with strong demand for minimally invasive diagnostics and quality-of-life-focused care. Australia benefits from established referral hospitals, veterinary schools, and advanced imaging access, while South Korea is supported by high urban pet ownership, modern clinics, and demand for specialized companion animal medicine. Across all countries, adoption is highest where general practitioners, diagnostic laboratories, surgeons, radiation centers, medical oncologists, and palliative care teams are connected through reliable referral pathways.

Actionable Recommendations for Veterinary Oncology Leaders

Industry leaders should prioritize integrated oncology pathways that connect primary veterinarians, diagnostic laboratories, imaging centers, surgeons, medical oncologists, radiation therapy providers, emergency teams, and palliative care specialists. Standardized staging protocols, tumor boards, survivorship plans, pain assessment tools, and owner education materials can improve treatment consistency, adherence, and trust.

Commercial strategies should focus on affordability, evidence, and access. Providers can expand through teleoncology, regional referral hubs, AI-assisted workflow tools, clinical trial partnerships, remote follow-up, and real-world outcomes registries. Manufacturers and service providers should invest in veterinary-specific indications, companion diagnostics, validated biomarkers, safety monitoring, pharmacovigilance, and post-authorization evidence to demonstrate measurable value for pets, owners, and clinicians.

Research Methodology for Veterinary Oncology Analysis

This executive summary is based on a structured review of verified public sources, including veterinary association guidance, regulatory databases, peer-reviewed veterinary oncology literature, animal health industry disclosures, clinical practice standards, academic publications, and regional pet care indicators. Emphasis is placed on data that can be corroborated through recognized veterinary, regulatory, academic, and industry sources, including disease burden evidence, approved therapeutic references, and professional specialty care standards.

The analysis applies market triangulation by comparing disease burden, pet ownership trends, specialty care availability, diagnostic adoption, regulatory approvals, clinical infrastructure, and regional veterinary service maturity. Qualitative insights are synthesized across demand drivers, technology adoption, competitive positioning, treatment access, and care delivery models to support decision-making in the veterinary oncology landscape without relying on market sizing, share estimates, or forecasts.

Conclusion: The Future of Veterinary Oncology

Veterinary oncology is entering a more data-driven and specialized phase as pet cancer diagnosis, treatment, and survivorship care become more accessible worldwide. Demand is reinforced by aging companion animals, owner willingness to pursue advanced care, and expanding clinical capabilities in diagnostics, surgery, radiation therapy, systemic therapy, immunotherapy, targeted treatment, pain control, and palliative medicine.

The next stage of development will depend on validated AI, stronger referral ecosystems, affordable treatment pathways, improved specialist training, and regionally appropriate service models. Organizations that combine clinical evidence, operational efficiency, compassionate communication, ethical care planning, and measurable outcomes will be best positioned in the global veterinary oncology landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Oncology Market, by Animal Type
7.1. Introduction
7.2. Canine
7.3. Equine
7.4. Exotic Pets
7.4.1. Aquatic Pets
7.4.2. Birds
7.4.3. Reptiles & Amphibians
7.5. Feline
8. Veterinary Oncology Market, by Treatment Mode
8.1. Introduction
8.2. Chemotherapy
8.2.1. Alkylating Agents
8.2.2. Antimetabolites
8.2.3. Cytotoxic Agents
8.2.4. Vinca Alkaloids
8.3. Immunotherapy
8.3.1. Cancer Vaccines
8.3.2. Monoclonal Antibodies
8.4. Radiotherapy
8.4.1. Brachytherapy
8.4.2. External Beam Radiotherapy
8.5. Surgery
8.6. Targeted Therapy
9. Veterinary Oncology Market, by Cancer Type
9.1. Introduction
9.2. Hemangiosarcoma
9.3. Lymphoma
9.4. Mammary Carcinoma
9.5. Mast Cell Tumors
9.6. Osteosarcoma
10. Veterinary Oncology Market, by Mode of Administration
10.1. Introduction
10.2. Intravenous (IV)
10.3. Oral
10.4. Topical
11. Veterinary Oncology Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Veterinary Hospitals & Clinics
12. Veterinary Oncology Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Veterinary Oncology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Veterinary Oncology Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. India
14.5. Japan
14.6. United Kingdom
14.7. Canada
14.8. Russia
14.9. Brazil
14.10. Italy
14.11. Mexico
14.12. France
14.13. Spain
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AB Science SA
16.2. Anivive Lifesciences
16.3. Ardent Animal Health, LLC
16.4. Boehringer Ingelheim International GmbH
16.5. Ceva Sante Animale S.A.
16.6. Covetrus, Inc.
16.7. Elanco Animal Health Incorporated
16.8. ELIAS Animal Health
16.9. Fidocure
16.10. IDEXX Laboratories, Inc.
16.11. Karyopharm Therapeutics Inc.
16.12. Leroy Biotech S.A.S.
16.13. Merck KGaA,
16.14. Morphogenesis, Inc.
16.15. Nippon Zenyaku Kogyo Co., Ltd.
16.16. PetCure Oncology LLC
16.17. PharmAust Limited
16.18. Rhizen Pharmaceuticals AG
16.19. Torigen Pharmaceuticals Inc.
16.20. Varian Medical Systems, Inc.
16.21. Vetco Pharmaceuticals Inc.
16.22. VetDC, Inc.
16.23. Virbac SA
16.24. VolitionRx Limited
16.25. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY ONCOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY ONCOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CANINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CANINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CANINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL EQUINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL EXOTIC PETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL EXOTIC PETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL EXOTIC PETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL AQUATIC PETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL AQUATIC PETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL AQUATIC PETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIRDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FELINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FELINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FELINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CHEMOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CHEMOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CHEMOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIMETABOLITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ANTIMETABOLITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIMETABOLITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CANCER VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CANCER VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL RADIOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TARGETED THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TARGETED THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TARGETED THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL LYMPHOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL LYMPHOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LYMPHOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL MAST CELL TUMORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL MAST CELL TUMORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MAST CELL TUMORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OSTEOSARCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OSTEOSARCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL OSTEOSARCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 131. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 132. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 133. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 134. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 135. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 136. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 138. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 151. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 152. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 153. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 154. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 155. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 156. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 157. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 158. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 162. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 163. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 164. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 165. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 166. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 167. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 169. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. GCC VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GCC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 172. GCC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 173. GCC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 174. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 175. GCC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 176. GCC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 177. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 178. GCC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 179. GCC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 192. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 193. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 194. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 195. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 196. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 197. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 198. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 199. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. G7 VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. G7 VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 202. G7 VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 203. G7 VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 204. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 205. G7 VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 206. G7 VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 207. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 208. G7 VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 209. G7 VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. NATO VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. NATO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 212. NATO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 213. NATO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 214. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 215. NATO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 216. NATO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 217. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 218. NATO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 219. NATO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. CHINA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 233. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 234. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 235. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 236. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 237. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 238. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 239. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 240. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. GERMANY VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 243. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 244. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 245. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 246. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 247. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 248. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 249. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. INDIA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 253. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 254. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 255. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 256. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 257. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 258. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 259. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 260. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. JAPAN VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 262. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 264. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 265. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 266. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 267. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 268. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 269. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 270. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. CANADA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 283. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 284. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 285. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 286. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 287. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 288. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 289. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 290. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 292. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. ITALY VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 313. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 314. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 315. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 316. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 317. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 318. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 319. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 320. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. MEXICO VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 322. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 323. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 324. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 325. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 326. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 327. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 328. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 329. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 330. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. FRANCE VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 332. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 333. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 334. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 335. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 336. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 337. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 338. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 339. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 340. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 341. SPAIN VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 342. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 343. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 344. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 345. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 346. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 347. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 348. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 349. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 350. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 351. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 352. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 353. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2017-2032 (USD MILLION)
TABLE 359. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 360. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 362. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 363. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2017-2032 (USD MILLION)
TABLE 364. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 365. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2017-2032 (USD MILLION)
TABLE 366. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2017-2032 (USD MILLION)
TABLE 367. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE,

Companies Mentioned

  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale S.A.
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech S.A.S.
  • Merck KGaA,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.74 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Veterinary Oncology Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Modality (Radiotherapy, Surgery, Chemotherapy, Immunotherapy, Other Treatments (Laser, Photodynamic, Focused Ultrasound)), Animal Type, Cancer Type - Product Image

Veterinary Oncology Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Modality (Radiotherapy, Surgery, Chemotherapy, Immunotherapy, Other Treatments (Laser, Photodynamic, Focused Ultrasound)), Animal Type, Cancer Type

  • Report
  • 160 Pages
  • Global
From
Veterinary Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 111 Pages
  • Global
From
Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Veterinary Oncology Market Report 2026 - Product Image

Veterinary Oncology Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Market

Veterinary Oncology is a specialized field of veterinary medicine that focuses on the diagnosis and treatment of cancer in animals. Veterinary oncologists are trained to diagnose and treat a variety of cancers, including lymphoma, mast cell tumors, and bone cancer. Treatment options may include chemotherapy, radiation therapy, and surgery. Veterinary oncologists also provide supportive care to help animals cope with the side effects of cancer treatment. Veterinary oncology is an important part of animal healthcare, as cancer is a leading cause of death in animals. Veterinary oncologists work closely with other veterinary specialists, such as surgeons and radiologists, to provide comprehensive care for animals with cancer. Some companies in the Veterinary Oncology market include VetDC, VetCancer, and VetCure Oncology. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.